Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-02-14 4:05 pm Purchase | 13G | CYCLERION THERAPEUTICS INC CYCN | TYNDALL CAPITAL PARTNERS L P | 164,429 6.7% | 42,791 (+35.18%) | View |
| 2024-02-09 5:06 pm Sale | 13G | CYCLERION THERAPEUTICS INC CYCN | Artal International S.C.A. | 138,955 5.7% | -2,640,167 (-95.00%) | View |
| 2024-02-09 08:50 am Purchase | 13G | CYCLERION THERAPEUTICS INC CYCN | FMR LLC | 162,849 6.66% | 162,849 (New Position) | View |
| 2024-01-22 3:44 pm Purchase | 13G | CYCLERION THERAPEUTICS INC CYCN | Slate Path Capital LP | 357,880 14.6% | 357,880 (New Position) | View |
| 2023-12-05 4:00 pm Purchase | 13D | CYCLERION THERAPEUTICS INC CYCN | Hecht Peter M | 840,899 26.9% | 322,435 (+62.19%) | View |
| 2023-09-05 4:05 pm Purchase | 13G | CYCLERION THERAPEUTICS INC CYCN | TYNDALL CAPITAL PARTNERS L P | 121,638 5.05% | 121,638 (New Position) | View |
| 2023-05-23 4:00 pm Purchase | 13D | CYCLERION THERAPEUTICS INC CYCN | Hecht Peter M | 518,464 19.99% | 518,464 (New Position) | View |
| 2023-05-12 08:39 am Purchase | 13D | CYCLERION THERAPEUTICS INC CYCN | Hecht Peter M | 10,369,298 19.99% | 6,149,640 (+145.74%) | View |
| 2023-04-03 07:30 am Purchase | 13D | CYCLERION THERAPEUTICS INC CYCN | Hecht Peter M | 4,219,658 9.2% | 19,606 (+0.47%) | View |
| 2023-02-09 09:59 am Purchase | 13G | CYCLERION THERAPEUTICS INC CYCN | FMR LLC | 3,420,963 7.865% | 803,553 (+30.70%) | View |
| 2023-01-13 4:30 pm Unchanged | 13G | CYCLERION THERAPEUTICS INC CYCN | Slate Path Capital LP | 7,157,601 16.5% | 0 (Unchanged) | View |
| 2022-11-21 5:00 pm Purchase | 13D | CYCLERION THERAPEUTICS INC CYCN | Hecht Peter M | 4,200,052 9.2% | 603,384 (+16.78%) | View |
| 2022-10-21 5:13 pm Unchanged | 13D | CYCLERION THERAPEUTICS INC CYCN | Slate Path Capital LP | 7,157,601 16.5% | 0 (Unchanged) | View |
| 2022-02-11 4:41 pm Purchase | 13G | CYCLERION THERAPEUTICS INC CYCN | Slate Path Capital LP | 7,157,601 16.49% | 961,538 (+15.52%) | View |
| 2022-02-11 06:35 am Purchase | 13G | CYCLERION THERAPEUTICS INC CYCN | Artal International S.C.A. | 2,779,122 6.4% | 961,538 (+52.90%) | View |
| 2022-02-09 09:31 am Purchase | 13G | CYCLERION THERAPEUTICS INC CYCN | MFN Partners LP | 3,389,215 7.8% | 3,389,215 (New Position) | View |
| 2022-02-09 09:11 am Sale | 13G | CYCLERION THERAPEUTICS INC CYCN | FMR LLC | 2,617,410 6.042% | -102,301 (-3.76%) | View |
| 2021-06-07 5:21 pm Purchase | 13D | CYCLERION THERAPEUTICS INC CYCN | Hecht Peter M | 3,596,668 8.6% | 823,170 (+29.68%) | View |
| 2021-05-14 4:56 pm Purchase | 13D | CYCLERION THERAPEUTICS INC CYCN | Hecht Peter M | 2,773,498 7.8% | 2,773,498 (New Position) | View |
| 2021-02-12 8:55 pm Sale | 13G | CYCLERION THERAPEUTICS INC CYCN | Artal International S.C.A. | 1,817,584 5.4% | -44,000 (-2.36%) | View |